Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

4.030

-0.070 (-1.71%)

At close: Aug 28, 2026, 4:00 PM EDT

4.035

+0.005 (0.12%)

After-hours: Aug 28, 2026, 4:10 PM EDT

Kalaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	43.17	98.05	1.64	3.17	3.06
Short-Term Investments	50.37	19.93	-	-	-
Cash & Short-Term Investments	93.54	117.98	1.64	3.17	3.06
Cash Growth	5.78%	7098.41%	-48.28%	3.60%	-
Prepaid Expenses	1.87	0.83	0.97	0.16	0.84
Total Current Assets	95.92	118.81	2.61	3.33	3.9
Property, Plant & Equipment	1.39	1.48	-	-	-
Long-Term Deferred Charges	-	-	3.15	-	-
Other Long-Term Assets	2.23	1.45	0.41	-	-
Total Assets	99.54	121.74	6.16	3.33	3.9

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	1.12	1.28	1.56	2.36	2.75
Accrued Expenses	7.27	8.12	2.15	1	2.52
Short-Term Debt	-	-	19.91	-	-
Current Portion of Leases	0.35	0.32	-	-	-
Other Current Liabilities	-	-	1.09	0.58	0.42
Total Current Liabilities	8.74	9.71	24.7	3.94	5.69
Long-Term Debt	-	-	-	-	3.25
Long-Term Leases	1.05	1.13	-	-	-
Other Long-Term Liabilities	32.08	32.08	32.08	-	0.26
Total Liabilities	41.87	42.92	56.78	3.94	9.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0	0	-	-	-
Additional Paid-In Capital	240.11	238.81	19.95	2.38	2.42
Retained Earnings	-182.37	-160	-116.56	-47.39	-32.7
Comprehensive Income & Other	-0.07	0.01	-	-	-
Total Common Equity	57.67	78.81	-96.62	-45.02	-30.27
Shareholders' Equity	57.67	78.81	-50.62	-0.61	-5.31
Total Liabilities & Equity	99.54	121.74	6.16	3.33	3.9

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	1.4	1.45	19.91	-	3.25
Net Cash (Debt)	92.14	116.53	-18.27	3.17	-0.19
Net Cash Growth	4.20%	-	-	-	-
Net Cash Per Share	4.30	7.63	-13.67	0.52	-0.04
Filing Date Shares Outstanding	23.8	22.93	18.7	6.76	4.44
Total Common Shares Outstanding	23.8	22.9	6.73	6.76	4.44
Working Capital	87.18	109.1	-22.1	-0.61	-1.79
Book Value Per Share	2.42	3.44	-14.36	-6.66	-6.81
Tangible Book Value	57.67	78.81	-96.62	-45.02	-30.27
Tangible Book Value Per Share	2.42	3.44	-14.36	-6.66	-6.81

SEC Filings: 10-K · 10-Q